Procurement of Medications: Oxytocin 5 IU, Magnesium Sulfate 2000mg, and Tamoxifen 20 mg CPA 1589

This tender is for the procurement of three essential medications: Oxytocin 5 IU, Magnesium Sulfate 2000mg, and Tamoxifen 20 mg. The reference number for this procurement is CPA 1589. Oxytocin is a hormone used to induce or augment labor, control postpartum bleeding, and manage incomplete abortion. Magnesium Sulfate is a versatile medication used in obstetrics to treat pre-eclampsia and eclampsia, and it also has applications in managing seizures and as a bronchodilator. Tamoxifen is a selective estrogen receptor modulator (SERM) primarily used in the treatment and prevention of breast cancer. The acquisition of these medications is vital for various medical departments, including obstetrics, gynecology, oncology, and critical care. The tender seeks to ensure a reliable supply of these critical drugs, which are fundamental to patient treatment protocols and emergency care. Bidders are expected to provide pharmaceutical-grade products that meet stringent quality and regulatory standards. The evaluation of proposals will likely consider price, product quality, manufacturer's reputation, and the ability to meet delivery schedules. This procurement underscores the commitment to maintaining adequate stock levels of essential medicines for patient safety and effective healthcare delivery.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 490.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.